Humoral Effect of SARS-CoV-2 mRNA vaccination with booster dose in solid tumor patients with different anticancer treatments

INTRODUCTION: Cancer patients are at risk for serious complications in case of SARS-CoV-2 infection. In these patients SARS-CoV-2 vaccination is strongly recommended, with the preferential use of mRNA vaccines. The antibody response in cancer patients is variable, depending on the type of cancer and...

Descripción completa

Detalles Bibliográficos
Autores principales: Piubelli, Chiara, Valerio, Matteo, Verzè, Matteo, Nicolis, Fabrizio, Mantoan, Carlotta, Zamboni, Sonia, Perandin, Francesca, Rizzi, Eleonora, Tais, Stefano, Degani, Monica, Caldrer, Sara, Gobbi, Federico Giovanni, Bisoffi, Zeno, Gori, Stefania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992722/
https://www.ncbi.nlm.nih.gov/pubmed/36910621
http://dx.doi.org/10.3389/fonc.2023.1089944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992722/
https://www.ncbi.nlm.nih.gov/pubmed/36910621
http://dx.doi.org/10.3389/fonc.2023.1089944

Ejemplares similares